Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59226 - 59250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	EGFR	1956	downregulated	Piroxicam results in decreased expression of EGFR mRNA	7p11.2	A23661
Piroxicam	Approved Investigational	EID1	23741	downregulated	Piroxicam results in decreased expression of EID1 mRNA	15q21.1	A23661
Piroxicam	Approved Investigational	EIF1AX	1964	downregulated	Piroxicam results in decreased expression of EIF1AX mRNA	Xp22.12	A23661
Piroxicam	Approved Investigational	EIF1AY	9086	downregulated	Piroxicam results in decreased expression of EIF1AY mRNA	Yq11.223	A23661
Piroxicam	Approved Investigational	EIF2S1	1965	downregulated	Piroxicam results in decreased expression of EIF2S1 mRNA	14q23.3	A23661
Piroxicam	Approved Investigational	EIF3J	8669	downregulated	Piroxicam results in decreased expression of EIF3J mRNA	15q21.1	A23661
Piroxicam	Approved Investigational	EIF4A2	1974	downregulated	Piroxicam results in decreased expression of EIF4A2 mRNA	3q27.3	A23661
Piroxicam	Approved Investigational	EIF4E	1977	downregulated	Piroxicam results in decreased expression of EIF4E mRNA	4q23	A23661
Piroxicam	Approved Investigational	EIF4E2	9470	downregulated	Piroxicam results in decreased expression of EIF4E2 mRNA	2q37.1	A23661
Piroxicam	Approved Investigational	EIF5	1983	downregulated	Piroxicam results in decreased expression of EIF5 mRNA	14q32.32	A23661
Piroxicam	Approved Investigational	EIF5B	9669	downregulated	Piroxicam results in decreased expression of EIF5B mRNA	2q11.2	A23661
Piroxicam	Approved Investigational	EPAS1	2034	downregulated	Piroxicam results in decreased expression of EPAS1 mRNA	2p21	A23661
Piroxicam	Approved Investigational	EPB41L2	2037	downregulated	Piroxicam results in decreased expression of EPB41L2 mRNA	6q23.1-q23.2	A23661
Piroxicam	Approved Investigational	ESM1	11082	downregulated	Piroxicam results in decreased expression of ESM1 mRNA	5q11.2	A23661
Piroxicam	Approved Investigational	EWSR1	2130	downregulated	Piroxicam results in decreased expression of EWSR1 mRNA	22q12.2	A23661
Piroxicam	Approved Investigational	EXOSC9	5393	downregulated	Piroxicam results in decreased expression of EXOSC9 mRNA	4q27	A23661
Piroxicam	Approved Investigational	EZH2	2146	downregulated	Piroxicam results in decreased expression of EZH2 mRNA	7q36.1	A23661
Piroxicam	Approved Investigational	F8A1	8263	downregulated	Piroxicam results in decreased expression of F8A1 mRNA	Xq28	A23661
Piroxicam	Approved Investigational	FAM111A	63901	upregulated	Piroxicam results in increased expression of FAM111A mRNA	11q12.1	A23661
Piroxicam	Approved Investigational	FAM129A	116496	downregulated	Piroxicam results in decreased expression of FAM129A mRNA	1q25.3	A23661
Piroxicam	Approved Investigational	FANCI	55215	upregulated	Piroxicam results in increased expression of FANCI mRNA	15q26.1	A23661
Piroxicam	Approved Investigational	FANCL	55120	upregulated	Piroxicam results in increased expression of FANCL mRNA	2p16.1	A23661
Piroxicam	Approved Investigational	FBXO9	26268	upregulated	Piroxicam results in increased expression of FBXO9 mRNA	6p12.1	A23661
Piroxicam	Approved Investigational	FDFT1	2222	downregulated	Piroxicam results in decreased expression of FDFT1 mRNA	8p23.1	A23661
Piroxicam	Approved Investigational	FDPS	2224	downregulated	Piroxicam results in decreased expression of FDPS mRNA	1q22	A23661

Displaying entries 59226 - 59250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability